Efficacy and Safety of Tislelizumab for Lung Adenocarcinoma With Asymptomatic Brain Metastatic
Clinical trial NCT06056115 · RECRUITING
Trial details
- NCT number
- NCT06056115
- Sponsor
- Hebei Medical University Fourth Hospital
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-01
- Primary completion
- 2025-04-12
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.